These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 702768)
1. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine. Miyazaki M Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768 [No Abstract] [Full Text] [Related]
2. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine. Miyazaki M Jpn Circ J; 1971 Sep; 35(9):1053-7. PubMed ID: 5172103 [No Abstract] [Full Text] [Related]
3. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine. Miyazaki M Eur Neurol; 1971-1972; 6(1):162-5. PubMed ID: 5153420 [No Abstract] [Full Text] [Related]
4. [Effects of various therapeutic agents on cerebral and peripheral circulation--aminophylline, papaverine, cyclandelate and isoxsuprine]. Miyazaki M Naika; 1972 Mar; 29(3):531-4. PubMed ID: 5035841 [No Abstract] [Full Text] [Related]
5. [Comparative effect of cyclandelate and papaverine on the cerebral circulation of the rabbit]. Dumery JP Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 980735 [No Abstract] [Full Text] [Related]
6. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients]. Petruzzi E; Bucalossi A Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469 [No Abstract] [Full Text] [Related]
7. [On the effect of papaverine and euphyllin on the cerebral and peripheral circulations]. Kozlova EN Klin Med (Mosk); 1966 Sep; 44(9):48-53. PubMed ID: 5995951 [No Abstract] [Full Text] [Related]
8. [Effects of vincamine on the mesenteric circulation in the rat. Microcirculatory evaluation of the vasodilator activity of vincamine]. Piacenza G; Pesce E Farmaco Prat; 1978 Jul; 33(7):326-32. PubMed ID: 744233 [No Abstract] [Full Text] [Related]
9. Measurement of cerebral blood flow by ultrasonic Doppler technique. Effects of several vasodilators on cerebral circulation, with special reference to aminophylline, nicotinic-acid and papaverine. Miyazaki M Jpn Circ J; 1966 Sep; 30(9):1023-9. PubMed ID: 6012758 [No Abstract] [Full Text] [Related]
10. Studies on the vincamine-papaverine association. VI. Interference with alpha receptors. Preliminary clinical evidence. Pedini G; Costa G; Bossi M; Manani G Agressologie; 1979; 20(4):221-3. PubMed ID: 233544 [No Abstract] [Full Text] [Related]
11. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders]. Petruzzi E; Bucalossi A; Chiostri R Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484 [No Abstract] [Full Text] [Related]
12. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers. Lim CC; Cook PJ; James IM Br J Clin Pharmacol; 1980 Jan; 9(1):100-1. PubMed ID: 7356869 [No Abstract] [Full Text] [Related]
13. Studies on the vincamine-papaverine association. V. Interference with alpha receptors. Experimental study. Costrini R; Nunziata A; Galloro P; Cattani L Agressologie; 1979; 20(4):217-20. PubMed ID: 233543 [No Abstract] [Full Text] [Related]
14. Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals. Cattani L; Costrini R; Manani G; Galzigna L; Giron GP; Costa G; Civran E; Bossi M Agressologie; 1978; 19(6):385-91. PubMed ID: 35999 [No Abstract] [Full Text] [Related]
15. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation. Palacios L; Roca J; Balasch J Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839 [No Abstract] [Full Text] [Related]
16. [Experimental studies on the effects of vincamine and its analogues on cerebrovascular circulation]. Imamoto T; Nukada T; Tada K No To Shinkei; 1977 Mar; 29(3):341-7. PubMed ID: 558779 [No Abstract] [Full Text] [Related]
17. Benefits of cyclandelate in the treatment of disorders of ageing. Le Poncin-Lafitte M Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325 [No Abstract] [Full Text] [Related]
18. [Effect of L-eburnamonine on bronchial respiratory resistance in the anesthetized guinea pig. Comparison with vincamine]. Linée P; Lacroix P; Laville MP; Le Pollès JB C R Seances Soc Biol Fil; 1978; 172(6):1208-13. PubMed ID: 159107 [TBL] [Abstract][Full Text] [Related]
19. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine]. Maeda T Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412 [No Abstract] [Full Text] [Related]
20. [Changes in cerebral electrogenesis caused by vincamine in the baboon, Papio papio]. Arfel G; de Pommery J; de Pommery H; de Lavarde M Rev Electroencephalogr Neurophysiol Clin; 1974; 4(1):53-67. PubMed ID: 4219639 [No Abstract] [Full Text] [Related] [Next] [New Search]